Before Stephen Ubl departed for a job as the chief lobbyist for the pharmaceutical industry, medtech's main man in Washington D.C. sat down with us to reflect on his time as CEO of AdvaMed. In this episode of DeviceTalks, we go deep into Ubl's background, the fights over the medical device tax, forging a new partnership with the FDA and more.